Skip to main content
PLOS One logoLink to PLOS One
. 2024 Sep 11;19(9):e0310358. doi: 10.1371/journal.pone.0310358

‘Was my kidney biopsy worth it?’–A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy

Michael Toal 1,*, Megan Raynor 2, Clare McKeaveney 2, Ciaran O’Neill 1, Michael Quinn 1, Christopher Hill 3, Alexander Peter Maxwell 1
Editor: Ankur Shah4
PMCID: PMC11389898  PMID: 39259730

Abstract

Background

Kidney biopsy is an important investigation in nephrology and facilitates the diagnosis of many conditions. It is an invasive procedure with the risk of significant complications, which limits its usage. There is minimal literature on how patients experience a kidney biopsy. Identifying and addressing barriers to access may expand opportunities for diagnosis and treatment. We hypothesise that patients experience kidney biopsy differently, depending on each individual’s circumstances.

Methods

Ten participants, who had undergone a total of twenty-three kidney biopsies were recruited through purposive sampling. They were interviewed about how they experienced the procedure, how they felt it had impacted their own medical care and about potential barriers and facilitators to access for other patients. A descriptive phenomenological approach was utilised and thematic analysis was applied to responses.

Results

Three main themes emerged: Unforeseen health concerns discovered, resilience and re-evaluation and the need for a patient-centred approach to biopsy. The experience of pain and discomfort varied amongst patients, but there was a significant emotional and psychological toll associated with kidney biopsy. All patients felt that the procedure had a positive impact on their treatment course through increased diagnostic information for them and their healthcare team. Further information in advance and the presence of trusted healthcare staff were identified as facilitators to kidney biopsy.

Conclusion

Kidney biopsy is experienced differently by patients. Improved information in advance by trusted healthcare professionals may reduce patient-related barriers to biopsy access.

Introduction

Kidney biopsy (KB) is an important investigation in nephrology and is the only way to definitively diagnose many renal disorders [1]. This is a routine procedure within nephrology units, with almost 2500 native kidney biopsies performed in Scotland over a five-year period and international native biopsy rates range from 10–230 procedures per million population per year [2]. KB is performed either as a day case or during an inpatient episode. Following the procedure, patients are normally asked to remain in bed for several hours of observations [3].

KB is an invasive procedure and as such is associated with potential complications. The most common complications relate to bleeding due to the highly vascular structure of the kidney. Most complications are self-limiting and do not result in significant adverse outcomes, but major complications can occur [3]. A perinephric haematoma has been observed on CT or ultrasound imaging in 57–91% of biopsies, however most individuals are asymptomatic [4, 5]. Macroscopic haematuria has been reported to occur in around 3% of KBs and 1% of patients require a blood transfusion. Major bleeding complications requiring radiological embolisation or nephrectomy are rare, occurring in 0.3% of biopsies. Death related to KB is exceptionally rare at 0.06% [6].

There is very limited reported literature exploring how patients experience undergoing this invasive procedure. A US study reported on 111 participants, 28 days after a protocol KB, and found that 63% of patients reported pain after the biopsy, but mostly below 4 on a 0–10 scale. 64% reported anxiety before biopsy, falling to 9% following the procedure [7]. A Danish qualitative study followed seven patients over a seven-hour period during their entire admission for KB [8]. These researchers described three main themes: patients required their basic needs to be met, they needed information and reassurance, and humour was used as a coping strategy [8].

This study aims to explore how patients experienced KB, how they perceived undergoing this procedure had impacted on their long-term care and what barriers and enabling factors could be identified to improve access to KB for other patients.

Materials and methods

Findings are reported in line with the consolidated criteria for reporting qualitative research (COREQ) guidelines [9]. Interviews were conducted by MT, a male specialist trainee doctor in nephrology. MT has trained in qualitative research methodologies through postgraduate education and has also performed many kidney biopsies in his clinical work, however he was not involved in the clinical care of any study participants. A participant information sheet (PIS) was produced and distributed to potential participants explaining the role of the interviewer, purpose of study and reassurance that their participation would remain confidential and have no impact on their medical care. Prior assumptions held by the interviewer were that patients may be reluctant to undergo an invasive procedure if they had minimal symptoms and the fear of pain acted as a barrier to biopsy.(10) A short explanatory video was produced in conjunction with the university media department to outline the rationale for the study, which included contact details for MT and the patient representative (MR). The video was disseminated through local and national kidney patient groups via email and social media outlets including: WhatsApp, Facebook, Instagram and Twitter/X.

Purposive sampling was used. Participants suitable for inclusion were adults over the age of 18 years at the time of interview, had self-reported to have had a KB under the care of a nephrologist, proficient English language skills to facilitate an interview and were able to give consent to participate. Individuals who came forward were sent a PIS in advance, then invited for a virtual interview which was conducted and recorded through Microsoft (MS) Teams or phone. Verbal consent was recorded before every interview and no contemporaneous field notes were taken.

The format of the interview was semi-structured (S1 Fig) and focused on the experience of kidney biopsy and reflections on how it has impacted care. Interviews were held from 20th March- 25th April 2023 with duration ranging from 9 to 32 minutes. Transcripts were not returned to participants before or after analysis and were generated using MS Teams software. The pre-specified criteria for data saturation were two consecutive interviews which yielded no new unique themes or subthemes, which was met after ten interviews had taken place.

A qualitative approach for this study involved phenomenology which aims to describe the lived experience of everyday phenomena as well as understand how people attribute meaning to that experience [10]. Neubauer et al explain that phenomenology “is to describe the meaning of this experience—both in terms of what was experienced and how it was experienced” [11]. Reflected in the current study, a phenomenology approach was used to understand the lived experiences of kidney biopsy and derive meaning unique to each individual [1214]. Complementary to this qualitative approach, Colaizzi’s descriptive phenomenological analysis was utilised to derive the lived experience using several steps. Following and in agreement with several authors, this was completed by step 6 [15, 16]. Firstly, the researchers studied the transcripts in detail to familiarise themselves with the findings and identify significant statements which could be used to formulate meaning, whilst using ‘bracketing’ to try to separate their own biases from influencing interpretation. Themes were then clustered into common experiences across all participants. These results were used to write a full description of the phenomenon in detail. The analysis was completed by condensing the description into succinct themes and subthemes that capture the essence of the phenomenon [14].

Coding was contemporaneous after each interview. Themes and subthemes were derived from transcripts by the interviewer (MT) and then transcripts were independently coded by an experienced qualitative researcher (CMcK). The final themes and subthemes were agreed following several meetings and discussions between MT and CMcK, as well as the wider research team.

Ethical approval for this project was granted by the Faculty of Medicine, Health and Life Sciences (FMHLS) Research Ethics Committee (REC) of Queen’s University Belfast (Project no. MHLS 22_175) on 15th February 2023. Research was conducted in accordance with the Helsinki declaration.

Results

Participants

Ten participants were recruited for the study, with no withdrawals. Baseline characteristics are described in Table 1. Six participants identified as female and four as male. Age at the time of interview ranged from 29–56 years. Age at the time of biopsy ranged from 14–47 years. Two participants lived in England, eight lived in Northern Ireland. One participant reported his ethnicity as British-Pakistani, all other participants identified as White. These ten individuals had undergone twenty-three kidney biopsies: six native and seventeen transplant biopsies. Nine participants had undergone a kidney transplant and one participant had chronic kidney disease.

Table 1. Baseline characteristics of interview participants.

RRT = renal replacement therapy. *Age unknown for two of four biopsies.

Identifier Age at interview Sex Ethnicity No. of biopsies Age at biopsy Biopsy subtype Current RRT
P1 47 Female White 1 29 Native Transplant
P2 38 Male White 2 34 Native Transplant
P3 41 Female White 2 23, 35 Native & Transplant Transplant
P4 43 Female White 2 32, 38 Transplant Transplant
P5 37 Male British-Pakistani 4 14*, 36 Transplant Transplant
P6 56 Male White 3 28, 47 Transplant Transplant
P7 29 Female White 2 17, 20 Transplant Transplant
P8 30 Female White 2 15, 21 Native & Transplant Transplant
P9 56 Female White 1 47 Native None
P10 46 Male White 4 31, 34 Native & Transplant Transplant

Main themes and sub-themes

Three main themes were identified: unforeseen health concerns discovered, resilience and re-evaluation and a patient-centred approach to kidney biopsy. Themes and subthemes are summarised in Table 2. Findings emphasised the physical and emotional impact of unexpected health concerns, the significance of coping and the consequences, and the importance of aligning treatment with the patient’s goals and values.

Table 2. Map of themes and subthemes emerging from interviews.

Themes Subthemes Explanation
Unforeseen health concerns discovered Deceptive health condition Participants reported minimal physical symptoms when abnormalities were detected
Unexpected emotional elements of biopsy The procedure invoked strong emotional reactions during and after the biopsy
Physical discomfort and monotony Participants described significant pain associated with the procedure and boredom during the long observation period
Resilience and re-evaluation Need for resilience Resilience of participants was tested due to the challenging circumstances that arose
Re-evaluation of priorities The period of illness and investigation prompted participants to reconsider their goals and responsibilities
Patient-centred approach to kidney biopsy Trusting staff Participants report feeling at ease when staff performing the biopsy were known and trusted by them already
Improved information provision Participants felt that further information about the process and potential results in advance of the biopsy would have alleviated their apprehension
Psychological support Some participants found their illness and medical care took an emotional toll and further psychological support may be warranted.

Theme 1: Unforeseen health concerns discovered

Sub-theme 1a: Deceptive health condition

The early stages of kidney disease are associated with subtle symptoms or can be entirely asymptomatic. For this reason, patients may be unaware of their condition until it proceeds to an advanced stage.

“(For) six months I was cramping after football on Friday night.”–P2

Over this period, some participants remarked that they were still able to function well and continue their normal activities, which were often of high intensity. Some found it difficult to understand how their kidney function could be so poor when they felt reasonably well.

“I was diagnosed, I had like 15% function left, which is on the one hand amazing that I was still standing and cycling”–P10

Sub-theme 1b: Unexpected emotional elements of biopsy

Attending for a KB was an emotionally challenging experience for many participants. Often, they were dealing with a new diagnosis of a serious medical condition and being asked to undergo an invasive procedure within a short space of time.

“Within 24 hours (from admission), they were saying that it’s looking like I need a transplant”–P2

“The sound of the biopsy was like a gun. I think that was the worst bit about it.”–P3

Difficulty with urination was noted by some female participants, as the strict bed rest made this challenging. The loss of autonomy and reliance on health professionals to fulfil basic needs placed a considerable emotional burden.

“It was a little bit humiliating, having nurses bring a bedpan.”–P1

“(Using a bed pan) was the most undignified experience I’ve ever had”–P3

Subtheme 1c: Physical discomfort and monotony

Participants experienced varying levels of physical discomfort during the KB. Some individuals reported severe pain both during the procedure and afterwards for several days.

“It’s (the) most painful thing I’ve ever felt in my life.”–P2

In contrast, many participants reported that they experienced minimal pain or discomfort associated with their kidney biopsy.

“I wasn’t in pain at all”–P3

After a kidney biopsy, patients are observed for 4 to 6 hours, which some participants found monotonous.

“You just keep on looking at the clock and it’s almost like the clock is stopped”–P6

Participants who had multiple kidney biopsies describe having a more positive experience of this aspect on subsequent procedures, as they came prepared with ways to occupy the time.

“I was more prepared (for the second biopsy). I brought more things with me in terms of doing a Sudoku or doing different bits and pieces”–P3

Theme 2: Resilience and re-evaluation

Sub-theme 2a: Need for resilience

Resilience was required not only for undergoing the procedure itself, but also for the consequent diagnosis and treatment. Participants demonstrated resilience to continue to live their lives to the full, despite these setbacks.

“I think I use humour to deflect from trying to remember everything and think about everything. But yeah, it’s had its ups and downs let’s say.”–P5

Some participants adopted a pragmatic approach and had the understanding that a kidney biopsy was a necessary step towards receiving the optimal medical care.

“Kidney biopsies are part and parcel of the process…it has to be done, so there’s no point stressing or worrying about it”–P4

Sub-theme 2b: Re-evaluation of priorities

Participants described a change in their attitude towards other people and life goals. Some felt a sudden change not only within their own lives, but also to others around them, placing a strain on established relationships.

“It’s opened my eyes to that bigger picture of, for me, who was there?”–P2

“My wife was very good, but she sort of kept me in the dark about certain things. You know, the kids were having trouble in school, which I didn’t learn until a year and a half later”–P2

One participant described a loss of identity and role, as he was no longer able to participate in activities he enjoyed, therefore losing social connections.

“When my kidneys failed when I was 28 years old that was the biggest thing that I missed was the ability to do rugby and the social aspect… I got a lot of satisfaction of playing the game and suddenly that was just taken away from me.”–P6

Theme 3: Patient-centred approach to kidney biopsy

Sub-theme 3a: Trusting staff

Many participants placed an enormous amount of trust in their medical team and highly valued the care they had received over a long period of time.

“I’m very lucky, I have great consultants, so they phoned me as soon as the results came in….. I had a lot of confidence in the people who were doing (the biopsies), so I suppose that helps.”–P4

Some participants reported that their anxiety surrounding the procedure was alleviated by the presence of healthcare staff that were known to and trusted by them.

“I think it was two biopsies performed by two different consultants. But I had complete trust in both”–P6

Participants valued the diagnostic certainty obtained from KB, both for themselves and their healthcare team, which helped guide their treatment.

“I think this is probably one of the best ways to really get under the hood and to see whether, you know, the kidney is really performing well. So I guess you can check your bloods and you can check all kinds of other things. But this is really getting into the machine itself…it gave me a lot of comfort knowing, for example, when I had that deterioration of function momentarily that I knew that there was nothing wrong”–P10

Sub-theme 3b: Improved information provision

Participants acknowledged that there were barriers and challenges associated with KB that were difficult for them or could be for patients in a similar position.

“I guess fear. I guess not fully understanding why it’s needed. What might be involved? How long it takes, but also how long afterwards it takes. What potential results could come back?”–P5

Participants reported anxiety associated with unknown elements of attending for the KB.

“(Advice for future patients)- I would say this is what’s gonna happen. This is what the machine looks like. It’s gonna be bloody scary. It’s a loud noise, prepare yourself for a loud noise. And over and above the things that you’re normally told, Prepare yourself for an extremely long wait.”P3

Sub-theme 3c: Psychological support

Some participants found the process of having a kidney biopsy, receiving a diagnosis and undergoing treatment overwhelming.

“My head wasn’t right. I found myself challenging everything”–P2

“I was in school and like, I was so stressed about, like keeping up with my peers,”–P7

Despite attempts to maintain normalcy through denial, the challenge of keeping pace with peers and confronting the reality of their condition ultimately brought about mental distress and internal conflict.

“So when (Doctor) left (after explaining the biopsy results), my mum came in and she had been crying. And so that set me off crying. And then we just sort of as a family sat and, like processed what was gonna happen….I was in denial. I thought there was nothing wrong with me. And then this was the actual final bit that confirmed well actually, this is going to be longer than I thought I would be in for”–P8

Participants also explored the facilitators that would lessen the burden and anxiety for patients coming forward for biopsy. The beneficial effect of social connections was revealed, as participants reported that having trusted staff around them or peer support from other patients could help overcome the barriers to access.

“I’d like to see much more kind of recognition of and acknowledgement of patient empowerment of their own mental health and wellbeing… I’m always kind of one that hammers on about peer support and getting patient peer support involved”–P6

Discussion

Participants varied in their experience of a KB. Participants reported differing degrees of pain associated with the biopsy procedure which appeared to be unrelated to sex or age. There did not appear to be any obvious associations to explain this discrepancy and perceptions of pain varied widely in this small group of participants, none of whom had a major complication of KB. The link between psychological distress and pain perception is well established and higher levels of pre-operative emotional distress has been shown to predict increased opioid use in the post-operative period [17].

Participants who had undergone a kidney transplant before their first biopsy appeared to better tolerate the procedure. There may be several reasons for this including the previous experience of an invasive procedure, a longer relationship with their healthcare team and a better awareness of the clinical environment. Additionally, the supine positioning for a transplant biopsy (rather than prone for native biopsy) could improve communication with the operator. However, contrasting the experience of native and transplant biopsies was not the objective of this study, therefore caution is warranted in interpretation.

Other factors like age and sex appeared less influential in experiences of a KB, however this is difficult to determine in a small study population. Rehearsing the processes required for kidney biopsy in the form of interactive resources or guided imagery may help alleviate anxiety, as participants reported that subsequent biopsies were generally better tolerated than their first experience.

The observation period after KB was challenging for individuals who were not equipped with resources to pass the time, but other participants used this time effectively. No major complications associated with KB occurred within this cohort.

The emotional and psychological toll of living with kidney disease should not be underestimated, which often persists despite successful transplantation [18]. Although the focus of this study was the impact of kidney biopsy, some participants described in detail their experience of living with kidney disease. Although this may not always be directly related to the biopsy, it is inevitably intertwined with their lived experience, as the biopsy occurred in the context of living with their disease. The participants who volunteered for this study appeared to be motivated to inform and support other patients by sharing their experience, as peer education is valued by patients living with kidney disease [19].

Limitations

This study has notable limitations. Transferability is limited, as the experience of only ten individuals is captured, who were often affiliated with patient groups and may have comparatively greater healthcare engagement. Recall bias may also influence responses, as there were many years between KB and interview for all participants. The interviewer (MT) from within the medical profession may have influenced how participants responded to questions. Opportunistic sampling resulted in some participants coming forward who knew MT through local patient groups, however he was not directly involved in the care of any participants.

Strengths

This study also has significant strengths. It acts as a solution to the main barrier reported by participants- a lack of information in advance. This study examines the process of KB from the patient’s perspective and should act as reassurance, as participants felt that transient discomfort has resulted in improved care. International rates of KB are highly variable [2]. By understanding patient-related barriers and enablers, healthcare providers should aim to mitigate circumstances that make it difficult for patients to come forward for biopsy, such as addressing limited healthcare literacy and adjusting for conflicting roles such as full-time carers or self-employed persons, to help improve equitable access to diagnosis and treatment of kidney disease.

Implications for future research

Larger and more diverse participant numbers are needed to capture unique circumstances, such as the effect of biopsy complications and how perception is influenced by life circumstances. A patient-centred approach to research offers the opportunity for patient stakeholders to guide research priorities to ensure that their needs are at the forefront of new developments. Kidney patient charities do have online resources for patients undergoing KB, however patients may not be aware of these and signposting by health professionals may help expand their usage [20, 21].

Conclusion

Participants who had undergone a KB reported varying degrees of physical and emotional distress, however the diagnostic information obtained was felt to have positively impacted their treatment course. Trust in healthcare professionals and accessible information in advance of the procedure, as well as guidance through the results and consequent treatment was highly valued. Further patient-centred research is needed to identify and remove systemic barriers to healthcare access.

Supporting information

S1 Fig. Semi-structured interview guide.

(TIF)

pone.0310358.s001.tif (690.8KB, tif)

Acknowledgments

The authors would like to thank the following patient groups for sharing information on this study through email and social media: Northern Ireland Kidney Patients Association, Transplant Sport Northern Ireland, Kidney Care UK and Young Adults Kidney Care Group UK. The promotional video was produced by Stephen Mullan, Video Resources Producer, Queen’s University Belfast (QUB).

Data Availability

Data cannot be shared publicly as the detailed qualitative data could be potentially disclosive if full transcripts were available to the public. The approving research ethics committee did not permit adding this data to a public repository and participants were not consented to have their data freely available. However, certain data may be available upon reasonable request by contacting Lorraine Carew, Research Ethics Officer, Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast at facultyrecmhls@qub.ac.uk.

Funding Statement

MT is supported by a research award from the Northern Ireland Kidney Research Fund. This organisation was not involved in the design or conduct of this study. https://nikidneyresearch.org/.

References

  • 1.Rovin BH, Adler SG, Barratt J, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021; 100: S1–S276. doi: 10.1016/j.kint.2021.05.021 [DOI] [PubMed] [Google Scholar]
  • 2.McQuarrie EP, MacKinnon B, Young B, et al. Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland. Nephrol Dial Transplant 2009; 24: 1524–1528. doi: 10.1093/ndt/gfn677 [DOI] [PubMed] [Google Scholar]
  • 3.Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy: Update and evidence for best practice. Clin J Am Soc Nephrol 2016; 11: 354–356. doi: 10.2215/CJN.05750515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Waldo B, Korbet SM, Freimanis MG, et al. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant 2009; 24: 2433–2439. doi: 10.1093/ndt/gfp073 [DOI] [PubMed] [Google Scholar]
  • 5.Whittier WL, Korbet SM. Timing of Complications in Percutaneous Renal Biopsy. J Am Soc Nephrol 2004; 15: 142–147. doi: 10.1097/01.asn.0000102472.37947.14 [DOI] [PubMed] [Google Scholar]
  • 6.Poggio ED, McClelland RL, Blank KN, et al. Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol 2020; 15: 1595–1602. doi: 10.2215/CJN.04710420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Victoria-Castro AM, Corona-Villalobos CP, Xu A, et al. Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project. Clin J Am Soc Nephrol; 10. [DOI] [PMC free article] [PubMed]
  • 8.Finderup J, Peschardt L, Sander MR, et al. How do patients experience a kidney biopsy? J Ren Care 2016; 42: 137–143. doi: 10.1111/jorc.12161 [DOI] [PubMed] [Google Scholar]
  • 9.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349–357. doi: 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 10.Cresswell JW, Poth CN. Qualitative inquiry and research design: Choosing among five approaches. 4th ed. Thousand Oaks, CA: Sage publications, 2016. [Google Scholar]
  • 11.Neubauer BE, Witkop CT, Varpio L. How phenomenology can help us learn from the experiences of others. Perspect Med Educ 2019; 8: 90–97. doi: 10.1007/s40037-019-0509-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jang H-Y;, Yang J-E, Shin Y-S, et al. Citation: A Phenomenological Study of Nurses’ Experience in Caring for A Phenomenological Study of Nurses’ Experience in Caring for COVID-19 Patients. Int J Environ Res Public Health; 19. Epub ahead of print 2022. doi: 10.3390/ijerph [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Teherani A, Martimianakis T, Stenfors-Hayes T, et al. Choosing a Qualitative Research Approach. J Grad Med Educ 2015; 7: 669–670. doi: 10.4300/JGME-D-15-00414.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Morrow R, Rodriguez A, King N. Colaizzi’s descriptive phenomenological method. Psychologist 2015; 28: 643–644. [Google Scholar]
  • 15.Ataro G., Methods methodological challenges and lesson learned from phenomenological study about OSCE experience: Overview of paradigm-driven qualitative approach in medical education. Ann Med Surg 2020; 49: 19–23. doi: 10.1016/j.amsu.2019.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Giorgi A. Concerning Variations in the Application of the Phenomenological Method. Humanist Psychol 2006; 34: 305–319. [Google Scholar]
  • 17.Borges RB, Caumo W, Bavaresco C, et al. The brief measure of preoperative emotional stress screens preoperative maladaptive psychological features and predicts postoperative opioid use: an observational study. Braz J Anesthesiol 2023; 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.McKeaveney C, Noble H, Courtney AE, et al. Dialysis, Distress, and Difficult Conversations: Living with a Kidney Transplant. Healthcare (Basel); 10. Epub ahead of print 1 July 2022. doi: 10.3390/healthcare10071177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: Systematic review and thematic synthesis of qualitative studies. BMJ; 340. Epub ahead of print 19 January 2010. doi: 10.1136/bmj.c112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kidney Biopsy. National Kidney Foundation, https://www.kidney.org/atoz/content/kidney-biopsy (accessed 9 November 2023).
  • 21.Kidney biopsy Working together for better patient information. Kidney Care UK, https://www.kidneycareuk.org/about-kidney-health/kidney-biopsy/ (accessed 9 November 2023).

Decision Letter 0

Ankur Shah

10 Jul 2024

PONE-D-23-42064"Was my kidney biopsy worth it?" A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsyPLOS ONE

Dear Dr. Toal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 24 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ankur Shah

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“MT is supported by a research award from the Northern Ireland Kidney Research Fund. This organisation was not involved in the design or conduct of this study.

https://nikidneyresearch.org/”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found.

4. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study ist about the the physiological (pain of the procedure...) and psychological aspects (stress, anxiety and felt impact of the treatment course...) of kidney biopsy. The kidney biopsy is an invasive, important diagnostic methode in the nephrology. The study is retrospective and includes 10 partecipants, wich undergoes 23 kidney biopsies. There were used questionnaires. There were included patients with CKD and also kidney transplanted patients.

Up to now there are existing only few studies about the physic and psychological impact in patients. This is a very interestning and import argument. Very simple and clear the introducion and objectives of the study. Methode is simple.

The discussion could be more precise:

- Interestning is for example the impact of the age: how is the resilience in elder patients, have elder patients more pain? How do you explain the results

- It is also interestning to investigate the results from patients which the native kidney was biopsied versus these which the transplanted kidney was biopsied. Differed the answers of the questionnaires in the groups? How do you explained?

- It is also interestning to specified in the table the motivation of kidney biopsy: Acute kidney injury (AKI); nephrotic syndrome; autoimmune systemic disease with suspect renal manifestation? How differ the answers in the questionnaire?

- Many patients ondergoes multiple kidney biopsy: How is their resilience, pain, felt impact in treatment course? Are differences in confront to patients which ungergoes only one kidney biopsy?

Reviewer #2: This is an interesting study by Toal et al describing the patient perspective of undergoing a kidney biopsy using a phenomenological approach.

Overall, the methodology is well described and the core elements of the reporting checklist have been adhered to, which are strengths. I appreciate the context that this is a phenomenological approach, which has some strengths and weaknesses. I believe this would be a meaningful contribution to the literature, but I also have some concerns that I hope the authors could address to strengthen the manuscript.

Major concerns:

1) The context for each theme feels limited, and the representative quotes do not appear to fully justify some components of the Discussion. For example, the authors note in the Discussion section that "the individual who reported the most severe pain also described a significant psychological burden resulting from their kidney disease." However, the quotes in the Results section do not sufficiently describe this psychological burden. It would be helpful to add a few more quotes to the results section, perhaps in a Table or in the main body of the paper. This could help add more context for the general reader for each theme and subtheme outlined in the paper.

2) I struggled with some aspects of the discussion and results. In particular, I felt that the purpose of the paper was to describe the patient perspective of undergoing a kidney biopsy. However, there were a few sections that appeared to focus more on the experience of living with kidney failure, and were not necessarily related to receiving a kidney biopsy (for example, the notion of having cramps after football, or losing the ability to play rugby). It would be helpful to either clarify this differentiation more explicitly, or mention in the limitations section that some of the experiences described were related to kidney failure and not necessarily to kidney transplantation.

3) To help the general reader understand the methodology better, please provide more description as to how the qualitative findings were independently verified by an experienced researcher. For example, did the first author and this experienced researcher meet several times to go over the themes and come to consensus? Did the experience qualitative researcher provide asynchronous feedback by email? Did new themes or concepts emerge from these discussions? A fuller description of this approach could help reduce concerns of the undue influence of Dr. Toal's role as a nephrologist who performs kidney biopsy (on a side note, I acknowledge and appreciate that Dr. Toal went to great lengths to describe his position, his own potential biases, and his reflexivity in the methodology section of the paper!)

4) The authors go to great detail to discuss and differential whether biopsies were performed on native or transplant kidneys. However, I did not notice any discussion about whether patient perspectives were similar or different when they received a native or transplant biopsy. From a grounded theory approach, one would assume that these perspectives would be very different. I appreciate that this nuance may not emerge from a phenomenological approach, however, if it did emerge, it would be worth noting. If it did not emerge, please consider describing this in the limitations.

5) Similarly, please provide justification for why the authors chose to use a phenomenological approach over a grounded theory approach. It is reasonable to pursue a phenomenological approach here, but discussing the rationale for choosing this approach would help strengthen the paper.

Minor comments:

1) In the background section, please provide more information on the incidence of kidney biopsies. If I were to just read the paper without any other clinical context, I'm not sure I would understand how big of a problem the authors are trying to tackle.

2) The authors discuss that the findings may have limited generalizability. As this is a qualitative study, please consider discussing transferability instead of generalizability.

3) The authors discuss how their work could help inform equitable access to care. However, it was not clear to me how the authors could link their work to health equity. I did not see a clear delineation of disparities in kidney biopsies, or how this patient perspective could address disparities. I do note that the interview guide asked for ethnicity of participants, however the body of the paper des not mention ethnicity. Please consider including ethnicity data. Please also consider adding a stronger rationale for how the study could potentially improve equitable access, or consider removing this section altogether.

Reviewer #3: Toal et all carried out structure interviews with 11 patients who had undergone 23 kidney biopsies to get a sense of the themes of patient experience. The selection process was purposive, and the sample size, so no way to see if experience of participants who underwent native biopsy different from those who underwent transplant biopsies. A couple issues should be addressed.

1. Authors note the importance of knowing the person who performed the biopsy. But they note that MT as a physician may have influenced their results. How many of the biopsies did MT perform and how might that have influenced the interviews?

2. The psychological effects of the illness don’t seem a direct consequence of the biopsy but a consequence of the diagnosis that grew out of the biopsy. How do the authors tie this in with the biopsy.

3. Can the authors speculate if there would be a difference between those who underwent native kidney biopsies and those who underwent allograft biopsies. Native biopsy patients have no idea what’s happening unless the operator tells them in advance since they’re lying on their stomach.

4. Did any of the 10 suffered untoward consequences like bleeding, hematuria, hematoma after biopsy? How might the experience of those who experienced a complication differ from those who did not? If no one in the study group suffered a complication how generalizable are the findings to those patients?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: George Bayliss, MD

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Sep 11;19(9):e0310358. doi: 10.1371/journal.pone.0310358.r002

Author response to Decision Letter 0


9 Aug 2024

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study ist about the the physiological (pain of the procedure...) and psychological aspects (stress, anxiety and felt impact of the treatment course...) of kidney biopsy. The kidney biopsy is an invasive, important diagnostic methode in the nephrology. The study is retrospective and includes 10 partecipants, wich undergoes 23 kidney biopsies. There were used questionnaires. There were included patients with CKD and also kidney transplanted patients.

Up to now there are existing only few studies about the physic and psychological impact in patients. This is a very interestning and import argument. Very simple and clear the introducion and objectives of the study. Methode is simple.

The discussion could be more precise:

Q1A- Interestning is for example the impact of the age: how is the resilience in elder patients, have elder patients more pain? How do you explain the results

A1A: Thank you for raising this point. In our small sample there did not appear to be any clear relationship between age and pain perception. The participant who was youngest at the time of biopsy (14 years) reported minimal pain, as did the oldest participants at time of biopsy (47 years). Although there was no clear correlation between age and perceptions of pain in this study, further research with larger cohorts would be required to try and answer this question.

Q1B- It is also interestning to investigate the results from patients which the native kidney was biopsied versus these which the transplanted kidney was biopsied. Differed the answers of the questionnaires in the groups? How do you explained?

A1B: This is an important point and has also been raised by the other reviewers. Participants who had undergone a kidney transplant before their first biopsy appeared to better tolerate the procedure. There may be several reasons for this relating to the positioning of the patient, their previous experience of invasive procedures in the form of transplant surgery and familiarity with the clinical environment and staff. However this study did not control for these factors, therefore a cautious approach is required in interpretation, as this is beyond the scope of what can be determined by this qualitative approach.

-Q1C It is also interestning to specified in the table the motivation of kidney biopsy: Acute kidney injury (AKI); nephrotic syndrome; autoimmune systemic disease with suspect renal manifestation? How differ the answers in the questionnaire?

A1C: As you rightly point out, there are many situations which may warrant a kidney biopsy, which may precipitate differing experiences for patients. The researchers did not have access to the medical records of participants; therefore these details are incomplete. Participants did volunteer their journey to a kidney biopsy in their own words, which provides some insight into the indications. In this study, several individuals had significant symptoms at the time of the biopsy, such as haemoptysis and leg oedema. Some individuals who were already symptomatic appeared to tolerate the procedure better than asymptomatic persons, however this was not consistent across the entire cohort.

Q1D- Many patients ondergoes multiple kidney biopsy: How is their resilience, pain, felt impact in treatment course? Are differences in confront to patients which ungergoes only one kidney biopsy?

A1D: In this study, 8 out of 10 participants underwent multiple kidney biopsies. In most cases, participants reported that the subsequent biopsies were better tolerated than their first biopsy. However, concluding that subsequent biopsies are better tolerated than the first is beyond the remit of qualitative research.

We would suggest that one reason for this inference could be that participants knew what to expect from the procedure, rather than fearing the unknown. Another important issue was that participants who were undergoing a repeat kidney biopsy were aware of the long clinical observation time and brought resources with them to pass the time, minimising the monotony associated with a long observation period.

Reviewer #2: This is an interesting study by Toal et al describing the patient perspective of undergoing a kidney biopsy using a phenomenological approach.

Overall, the methodology is well described and the core elements of the reporting checklist have been adhered to, which are strengths. I appreciate the context that this is a phenomenological approach, which has some strengths and weaknesses. I believe this would be a meaningful contribution to the literature, but I also have some concerns that I hope the authors could address to strengthen the manuscript.

Major concerns:

Q2A: 1) The context for each theme feels limited, and the representative quotes do not appear to fully justify some components of the Discussion. For example, the authors note in the Discussion section that "the individual who reported the most severe pain also described a significant psychological burden resulting from their kidney disease." However, the quotes in the Results section do not sufficiently describe this psychological burden. It would be helpful to add a few more quotes to the results section, perhaps in a Table or in the main body of the paper. This could help add more context for the general reader for each theme and subtheme outlined in the paper.

A2A: Thank you for raising this point. We have added additional participant quotes to help expand these themes. These additional quotes provide more insights into areas detailed in the discussion. Upon deliberation within the research team, we concluded that it was not constructive to highlight the psychological distress of just one individual, as all participants describe varying degrees of a physical and emotional burden relating to their biopsy and related kidney disease. Therefore this sentence has been removed from the discussion section.

Q2B: 2) I struggled with some aspects of the discussion and results. In particular, I felt that the purpose of the paper was to describe the patient perspective of undergoing a kidney biopsy. However, there were a few sections that appeared to focus more on the experience of living with kidney failure, and were not necessarily related to receiving a kidney biopsy (for example, the notion of having cramps after football, or losing the ability to play rugby). It would be helpful to either clarify this differentiation more explicitly, or mention in the limitations section that some of the experiences described were related to kidney failure and not necessarily to kidney transplantation.

A2B: The reviewer is correct that the main purpose of the paper was to describe the patient perspective of undergoing a kidney biopsy. This is a key issue that has not been well described previously in the literature. The focus of the study was to try and understand the lived experience of having a kidney biopsy, however many participants took this opportunity to also describe, in great detail, their experience of living with kidney disease. Although this is not always directly related to the biopsy, this procedure occurred within the context of their illness (kidney disease), therefore the two are inevitably intertwined through the patient journey. We felt it was important to depict the mental health context in which patients are asked to undergo this invasive procedure, as these individuals’ vulnerability is further tested on top of the physical and emotional toll of their illness. This point has been expanded further in the discussion section.

Q2C: 3) To help the general reader understand the methodology better, please provide more description as to how the qualitative findings were independently verified by an experienced researcher. For example, did the first author and this experienced researcher meet several times to go over the themes and come to consensus? Did the experience qualitative researcher provide asynchronous feedback by email? Did new themes or concepts emerge from these discussions? A fuller description of this approach could help reduce concerns of the undue influence of Dr. Toal's role as a nephrologist who performs kidney biopsy (on a side note, I acknowledge and appreciate that Dr. Toal went to great lengths to describe his position, his own potential biases, and his reflexivity in the methodology section of the paper!)

A2C: This is an important methodological issue, thank you for raising this. We have added further detail within the manuscript of how the stepwise method for Colaizzi’s phenomenological approach was utilised. The first author (MT) identified codes independently in the first instance. Subsequently he met with the experienced qualitative researcher (CMcK) to outline the purpose of the study and relevant methodologies. She then read two sample transcripts, which were the most comprehensive and contrasting and coded these independently, blinded to the initial codes. These new themes were then discussed iteratively to derive new codes, and then expanded to the other transcripts. Each draft of the manuscript was read and amended by CMcK to maintain consistent coding across all participants.

Q2D: 4) The authors go to great detail to discuss and differential whether biopsies were performed on native or transplant kidneys. However, I did not notice any discussion about whether patient perspectives were similar or different when they received a native or transplant biopsy. From a grounded theory approach, one would assume that these perspectives would be very different. I appreciate that this nuance may not emerge from a phenomenological approach, however, if it did emerge, it would be worth noting. If it did not emerge, please consider describing this in the limitations.

A2D: This qualitative study did not control for distinctions between the lived experience of individuals who undergo native and transplant biopsies, therefore a cautious approach is required in interpretation. Utilising a phenomenological approach in this small cohort, the lived experience of participants who had been previously transplanted at the time of their first biopsy may have been different to those who had not. There may be several reasons for this relating to the positioning of the patient, their previous experience of invasive procedures in the form of transplant surgery and familiarity with the clinical environment and staff. However further research would be needed to draw firm conclusions in this area.

Q2E: 5) Similarly, please provide justification for why the authors chose to use a phenomenological approach over a grounded theory approach. It is reasonable to pursue a phenomenological approach here, but discussing the rationale for choosing this approach would help strengthen the paper.

A2E: We agree with the reviewer that there are alternate qualitative research approaches to try and answer research questions.

A phenomenological approach was used to understand the direct ‘lived experiences’ of the patients undergoing a kidney biopsy i.e. we were interested in their own subjective understanding of having a kidney biopsy. There is a paucity of relevant literature in this area. If there were prohibiting circumstances that could prevent patients coming forward for biopsy, this could act as a barrier to timely diagnosis and treatment.

This explanation has been expanded in the manuscript for a more thorough justification of the methodological decision.

Minor comments:

Q2F: 1) In the background section, please provide more information on the incidence of kidney biopsies. If I were to just read the paper without any other clinical context, I'm not sure I would understand how big of a problem the authors are trying to tackle.

A2F: We agree entirely that this would help to provide context for the paper. Details of biopsy numbers within one region of the UK and internationally in terms of rates per million population annually have been added in the Introduction to the manuscript.

Q2G: 2) The authors discuss that the findings may have limited generalizability. As this is a qualitative study, please consider discussing transferability instead of generalizability.

A2G: Thank you for spotting this error. We have changed this to transferability.

Q2H: 3) The authors discuss how their work could help inform equitable access to care. However, it was not clear to me how the authors could link their work to health equity. I did not see a clear delineation of disparities in kidney biopsies, or how this patient perspective could address disparities. I do note that the interview guide asked for ethnicity of participants, however the body of the paper des not mention ethnicity. Please consider including ethnicity data. Please also consider adding a stronger rationale for how the study could potentially improve equitable access, or consider removing this section altogether.

A2H: This is an important point you have raised. Data on ethnicity has now been added. In terms of access to care, the authors do not propose that certain groups of individuals defined by age, sex or race are systematically disadvantaged with poorer access to kidney biopsy. We sought to examine the origins of patient reluctance or hesitation when this investigation was recommended by their healthcare provider. Specific patient-related factors may limit uptake, such as childcare provision to mothers of young children or loss of income for self-employed individuals. In our study, women reported specific challenges relating to urination whilst on bedrest during the observation period, which is a potential disparity that could be highlighted in advance for female patients. Understanding which patient-related barriers contribute to biopsy hesitancy allows for healthcare professionals to adapt services to help ensure individuals who are deemed to require this procedure can access it.

Reviewer #3: Toal et all carried out structure interviews with 11 patients who had undergone 23 kidney biopsies to get a sense of the themes of patient experience. The selection process was purposive, and the sample size, so no way to see if experience of participants who underwent native biopsy different from those who underwent transplant biopsies. A couple issues should be addressed.

Q3A: 1. Authors note the importance of knowing the person who performed the biopsy. But they note that MT as a physician may have influenced their results. How many of the biopsies did MT perform and how might that have influenced the interviews?

A3A: MT was not involved in the direct clinical care of any of the individuals who participated in the study at any point. Therefore, he performed none of the biopsies on these patients. MT has performed approximately 50 kidney biopsies across a five-year career in nephrology at the time of interview, however none of the patients he had biopsied were included in this study.

Q3B: 2. The psychological effects of the illness don’t seem a direct consequence of the biopsy but a consequence of the diagnosis that grew out of the biopsy. How do the authors tie this in with the biopsy.

A3B: This is an important distinction and has been highlighted by other reviewers. The kidney biopsy occurred within the context of each individual’s illness and the associated physical and emotional toll. We felt it was important to provide context to the reader that this invasive procedure was undertaken at a time when the participant was already vulnerable. The psychological effects may not have always been directly related to the procedure; however the biopsy was undertaken during the patient journey of living with their illness, therefore we felt it was important to allow participants to explain what this meant to them within that framework.

Q3C: 3. Can the authors speculate if there would be a difference between those who underwent native kidney biopsies and those who underwent allograft biopsies. Native biopsy patients hav

Attachment

Submitted filename: Response to Reviewers_PLoS One_.docx

pone.0310358.s002.docx (33KB, docx)

Decision Letter 1

Ankur Shah

30 Aug 2024

'Was my kidney biopsy worth it?' - A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy

PONE-D-23-42064R1

Dear Dr. Toal,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ankur Shah

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Manuscript Number: PONE-D-23-42064R1

Manuscript Title: 'Was my kidney biopsy worth it?' - A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy

The suggestions for improvement have been well implemented in the revised version.

The number of kidney biopsies in Scotland and international was added. Ethnicities were included in the description of the collectives.

The proposed aspects were addressed in the discussion: It is clear to the reader that no conclusions can be drawn from this data regarding interpretation in terms of age and gender as the collective is limited in number. It is stated that both second biopsies and biopsies in kidney transplant patients are better tolerated. Probable reasons are also given: Previous experience with invasive investigations results in higher tolerance.

Reviewer #3: The authors have addressed my concerns. Many of my questions couldn't be addressed by the study as designed. So be it. It's still an interesting concept to look at the biopsy from the patient's perspective and in the perspective the illness. Several participants had native biopsies followed by biopsies. I'd love to know how their biopsy changed from a diagnostic procedure as they lost kidney function to one post-transplant. One other question that might be relevant is whether the transplant biopsies were done for cause or whether they were protocol biopsies for surveillance.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: Yes: George Bayliss, MD

**********

Acceptance letter

Ankur Shah

3 Sep 2024

PONE-D-23-42064R1

PLOS ONE

Dear Dr. Toal,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ankur Shah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Semi-structured interview guide.

    (TIF)

    pone.0310358.s001.tif (690.8KB, tif)
    Attachment

    Submitted filename: Response to Reviewers_PLoS One_.docx

    pone.0310358.s002.docx (33KB, docx)

    Data Availability Statement

    Data cannot be shared publicly as the detailed qualitative data could be potentially disclosive if full transcripts were available to the public. The approving research ethics committee did not permit adding this data to a public repository and participants were not consented to have their data freely available. However, certain data may be available upon reasonable request by contacting Lorraine Carew, Research Ethics Officer, Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast at facultyrecmhls@qub.ac.uk.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES